Skip to main content
. 2022 Dec;81(12):328–332.

Table 3.

Mean Systolic and Diastolic Blood Pressure of Participants Undergoing Dilation and Evacuation Who Received Placebo (n=56) or Oxytocin (n=56) Measured at Enrollment and Throughout the Procedurea

Time of Blood Pressure Measurement Placebo Oxytocin
Systolic
Mean ± SD
Diastolic
Mean ± SD
Systolic
Mean ± SD
Diastolic
Mean ± SD
Enrollment 113.6 ± 13.2 72.6 ± 9.0 113.8 ± 15.2 73.0 ± 8.6
Procedure start 121.5 ± 13.6 69.0 ± 12.8 122.5 ± 16.2 69.4 ± 10.1
Medication provision 112.9 ± 18.8 64.9 ± 15.8 114.0 ± 18.0 63.5 ± 12.9
5 minutes 106.3 ± 15.9 60.0 ± 14.3 105.2 ± 16.8 59.0 ± 11.6
10 minutes 103.3 ± 12.8 58.1 ± 12.2 102.1 ± 13.2 56.1 ± 8.5
15 minutes 102.6 ± 14.0 56.1 ± 11.9 101.7 ± 11.9 55.6 ± 9.8
20 minutes 102.1 ± 11.1 55.9 ± 10.4 101.7 ± 9.9 55.4 ± 7.9
25 minutes 101.0 ± 10.0 54.5 ± 10.3 103.6 ± 8.6 56.7 ± 8.7
30 minutes 102.7 ± 12.1 55.1 ± 13.6 105.6 ± 9.0 58.6 ± 7.4
35 minutes 104.9 ± 12.6 56.9 ± 12.5 104.3 ± 9.3 58.7 ± 7.3
a

Procedure duration varied so some patients did not have blood pressure measurements at all time points after 15 minutes (at 15 minutes: placebo (n=53) and oxytocin (n=53), at 20 minutes: placebo (n=44) and oxytocin (n=46), at 25 minutes placebo (n=33) and oxytocin (n=36), at 30 minutes: placebo (n=28) and oxytocin (n=25), at 35 minutes placebo (n=18) and oxytocin (n=15).